MK-0626
MK-0626 is an oral DPP-4 inhibitor that reduces hepatic steatosis via AMPK activation and protects pancreatic islets in diabetic models by upregulating GLP-1R. It also promotes angiogenesis by increasing endothelial progenitor cells and eNOS expression, making it a useful research tool for studying metabolic and cardiovascular diseases.
Product Specifications
CAS Number
690257-74-0
Product Name Alternative
MK0626, MK-0626, MK-0626 free base, MK 0626
Field of Research
Epigenetics & Chromatin, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.47% (May vary between batches)
Smiles
[C@H] ([C@@H] (C (=O) N1CC (F) (F) CC1) N) (C (N (C) C) =O) C2=CC=C (C=C2) C3=CN4C (C=C3) =NC=N4
Molecular Formula
C22H24F2N6O2
Molecular Weight
442.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0064706 1.0 µg DNA
AK3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 418590-01 500 mg
2-Methoxy-5-methyl-γ-phenylbenzenepropanol Methanesulfonate
Sign In for Pricing
View Details 418590-02 5 g
2-Methoxy-5-methyl-γ-phenylbenzenepropanol Methanesulfonate
Sign In for Pricing
View Details